QUFU, China, Oct. 14 /PRNewswire-FirstCall/ -- Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), one of the world''s leading producers of all-natural, zero-calorie Stevia in China and a leader in the production and distribution of Chinese herbs and veterinary medicines announced today it has received two key recognitions from Jining City in Shandong Province. Jining City is located in southwest Shandong Province and controls Qufu City, home to Sunwin''s global headquarters and main production facilities. Shandong Province is a key agricultural producer in China and records average GDP increases in excess of 10% with 2007 GDP growth of 16.3%.
Sunwin received recognition from the Jining City Scientific and Technology Bureau for the development of its proprietary high-grade stevia extraction and refinement technologies used in its stevia extract processes. This recognition is part of a larger program to encourage and recognize technological advancement in Jining City among its key industries, including agricultural production and export. Sunwin also received a certificate of approval of the Jining City Economic and Trade Committee under the Shandong Province''s first technological renovation plan. This document provides support to Sunwin at all levels of provincial and city government for licensing, grants, and banking and development needs to advance its provincial business initiatives for production and export.
Commenting on this achievement, Chairman Laiwang Zhang stated, "It is a great honor to be recognized by our government for Sunwin''s business accomplishments in Jining City. We look forward to working with the assistance of Jining''s Economic and Trade Committee as we further Sunwin''s stevia businesses for traditional markets in Asia and now the United States where Stevia is becoming recognized as a widely acceped all natural zero calorie sweetening alternative to sugar. We believe China produces the best stevia crops and extracts in the world, with Shandong Province playing a key role in the global stevia production market. We are excited to move ahead with our production enhancements in an effort to meet the increasing demand for high-grade stevia extracts suitable for many uses, especially in the United States where the stevia market continues to expand rapidly since the FDA granted the first stevia approvals for the food and beverage industry in December 2008."
Company Background
Sunwin International Neutraceuticals, Inc. engages in the areas of essential traditional Chinese medicine, zero calorie natural sweeteners (Stevia), and veterinary medicines and feeds prepared from 100 percent natural herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. For more info about Sunwin, please visit http://www.sunwininternational.com/.
Safe Harbor Statement
Sunwin International Neutraceuticals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance and expectations regarding revenues, net income and earnings.
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2009.
CONTACT: Company: Jeff Reynolds, (972) 377-2339, jreynolds@sunwinusa.com; Investors: Matt Kreps, The Shelton Group, (972) 239-5119 ext 125, mkreps@sheltongroup.com
Sunwin International Neutraceuticals Inc.
CONTACT: Company: Jeff Reynolds, (972) 377-2339,
jreynolds@sunwinusa.com; Investors: Matt Kreps, The Shelton Group, (972)
239-5119 ext 125, mkreps@sheltongroup.com
